Document Classification

Section Type: RESULTS

Text: At 6-month, the left ventricular (LV) end-systolic and end-diastolic diameters increased in the placebo group (LVESD : 29. 7 3. 4 to 33. 4 4. 5 mm ; LVEDD : 47. 2 3. 8 to 52. 0 4. 6 mm, p = 0. 01 for both) but remained unchanged in the nebivolol group (LVESD : 30. 4 3. 5 to 31. 0 3. 6 mm, p = 0. 20 ; LVEDD : 47. 0 4. 4 to 47. 1 4. 0 mm, p = 0. 93).